Couples' Communication and Quality of Life during Prostate Cancer Survivorship

前列腺癌幸存者期间夫妻的沟通和生活质量

基本信息

  • 批准号:
    7541530
  • 负责人:
  • 金额:
    $ 2.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-01 至 2009-06-19
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Prostate cancer is the most frequently diagnosed cancer and the second leading cause of cancer related deaths in men. Evidence suggests that prostate cancer and its treatment often involve the most intimate parts of the relationship between cancer patients and their partners, and thus, can have considerable negative effects on their quality of life (QOL) over an extended period of time. While coping with this "couple's illness," the communication between prostate cancer patients and their partners-the exchange of cancer-related information and concerns-plays an integral role in couples' daily life and the informal caregiving. Yet there has been little research on the relationship between communication and QOL in couples coping with prostate cancer. Fewer studies have concurrently examined the perspectives of both patients and their partners as it relates to their communication about the illness. There is also an absence of quantitative longitudinal research that examines how levels or patterns of communication change over time during prostate cancer survivorship. The purpose of this study is to describe changes in the levels of communication between prostate cancer patients and their partners over time, and to determine the amount of variance in their QOL that is accounted for by the Couple's Cancer Communication Model. Based on a secondary analysis of the longitudinal data obtained from a randomized clinical trial sponsored by the National Cancer Institute, two specific aims will be addressed in this study. Aim one is to describe the pattern of change in prostate cancer patients' and their partners' levels of communication from baseline to 4, and 8 month follow-ups. Aim two is to test the hypothesized relationships in the Couple's Cancer Communication Model designed to predict the QOL in prostate cancer patients and their partners. The results from this study will contribute to the body of knowledge pertaining to communication between prostate cancer patients and their partners, and their subsequent QOL. Furthermore, the study will provide valuable information that can be used to develop intervention strategies to assist couples to communicate more effectively and to support one another as they cope with the demands of prostate cancer. With an ultimate goal of optimizing the QOL for cancer survivors and their families, this research effort is in accordance with the research priorities of prominent scientific and funding agencies including the Institute of Medicine, the National Institute of Nursing Research, and the National Cancer Institute.
描述(由申请人提供):前列腺癌是最常见的癌症,也是男性癌症相关死亡的第二大原因。有证据表明,前列腺癌及其治疗通常涉及癌症患者与其伴侣之间关系中最亲密的部分,因此,在很长一段时间内会对其生活质量(QOL)产生相当大的负面影响。在应对这种“夫妇的病”时,前列腺癌患者与其伴侣之间的交流 - 与癌症相关的信息和关注 - 扮演在夫妻的日常生活和非正式护理中的重要作用。然而,关于应对前列腺癌的夫妻的沟通与QoL之间关系的研究很少。在与他们关于疾病的交流有关的情况下,同时研究的研究较少。还没有定量纵向研究,该研究研究了前列腺癌生存期间的交流水平或模式如何随着时间的流逝而变化。这项研究的目的是描述前列腺癌患者及其伴侣之间交流水平的变化,并确定夫妻癌症通信模型所解释的QOL的差异量。基于对国家癌症研究所赞助的随机临床试验获得的纵向数据的次要分析,本研究将解决两个具体目标。目的是描述前列腺癌患者及其伴侣的沟通水平从基线到4个和8个月的随访方式。目标二是测试这对夫妇的癌症通信模型中的假设关系,旨在预测前列腺癌患者及其伴侣的质量。这项研究的结果将有助于与前列腺癌患者及其伴侣以及随后的QOL之间的交流有关的知识体系。此外,该研究将提供有价值的信息,这些信息可用于制定干预策略,以帮助夫妻在应对前列腺癌的需求时进行更有效的沟通并互相支持。为了为癌症幸存者及其家人优化QOL的最终目标,这项研究工作符合著名的科学和资助机构的研究优先事项,包括医学研究所,国家护理研究所和国家癌症研究所。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Factors influencing prostate cancer screening in African American men.
  • DOI:
    10.1177/0193945910361332
  • 发表时间:
    2010-10
  • 期刊:
  • 影响因子:
    1.8
  • 作者:
    Lehto RH;Song L;Stein KF;Coleman-Burns P
  • 通讯作者:
    Coleman-Burns P
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lixin Song其他文献

Lixin Song的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lixin Song', 18)}}的其他基金

Efficacy of a Couple-focused, Tailored, Symptom Self-Management mHealth Intervention for Prostate Cancer Patients and Partners
以夫妻为中心、量身定制的症状自我管理移动健康干预措施对前列腺癌患者和伴侣的功效
  • 批准号:
    10200890
  • 财政年份:
    2017
  • 资助金额:
    $ 2.89万
  • 项目类别:
Enhancing Survivorship Care Planning for Patients with Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program
使用以夫妇为中心、基于网络的定制症状自我管理计划,加强局限性前列腺癌患者的生存护理计划
  • 批准号:
    9225993
  • 财政年份:
    2016
  • 资助金额:
    $ 2.89万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Reproductive history and later-life brain health: The Bogalusa Heart Study
生殖史和晚年大脑健康:Bogalusa 心脏研究
  • 批准号:
    10736169
  • 财政年份:
    2023
  • 资助金额:
    $ 2.89万
  • 项目类别:
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
米托醌/甲磺酸米托喹诺作为 Covid-19 的口服且安全的暴露后预防
  • 批准号:
    10727092
  • 财政年份:
    2023
  • 资助金额:
    $ 2.89万
  • 项目类别:
Gabapentinoid/opioid mixtures: abuse and toxicity
加巴喷丁/阿片类混合物:滥用和毒性
  • 批准号:
    10639396
  • 财政年份:
    2023
  • 资助金额:
    $ 2.89万
  • 项目类别:
Physical Frailty and Symptom Monitoring and Management Behaviors in Heart Failure (PRISM-HF)
心力衰竭的身体虚弱和症状监测和管理行为 (PRISM-HF)
  • 批准号:
    10740609
  • 财政年份:
    2023
  • 资助金额:
    $ 2.89万
  • 项目类别:
Class II Human Leukocyte Antigen biologics for antibody-mediated graft rejection.
用于抗体介导的移植物排斥反应的 II 类人类白细胞抗原生物制剂。
  • 批准号:
    10598931
  • 财政年份:
    2023
  • 资助金额:
    $ 2.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了